Retatrutide lacks marketing authorization in the EU and is being used as an underground marketplace for unregulated drugs.

The entities involved

• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.Mon 14:18
  • Both the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Fri 23:04
• TikTok →

  video-focused social media platform

  • PBS is leveraging social media platforms like YouTube, Instagram, and TikTok to grow its audience and attract top talent for future projects.Mon 17:13
  • The FBI is investigating election fraud in Los Angeles, following claims documented in a TikTok video.Mon 15:13

Related events

• EMA adopted a positive opinion and the European Commission granted marketing authorization for the drug Hopledo.Aug 28
• AbbVie submitted an application for risankizumab approval to the European Medicines Agency.Aug 27
• EMA validated marketing authorization and FDA accepted NDA for Pharvaris N.V.'s lead drug.Aug 25